Montana Code Annotated (2015)
Table of Contents / TITLE 50. HEALTH AND SAFETY / CHAPTER 32. CONTROLLED SUBSTANCES
Part 2. Scheduling of Dangerous Drugs
Current Version 2025, 2023, 2021, 2019, 2017, 2015, 2013, 2011, 2009, 2007, 2005, 2003, 2001, 1999, 1997, 1995
50-32-201 - General Criteria To Be Considered
50-32-202 - Designation Of Drug As Dangerous Drug
50-32-203 - Effect Of Rescheduling Under Federal Law
50-32-204 - Immediate Precursors
50-32-205 - Nonprescription Drugs Not To Be Scheduled
50-32-206 - Use Of Names Of Scheduled Drugs
50-32-207 - Order Forms For Drugs In Schedules I And Ii
50-32-208 - Prescription And Medical Requirements For Scheduled Drugs – Penalty
50-32-209 - Republication Of Schedules
50-32-210 - Through 50-32-220 Reserved
50-32-221 - Criteria For Placement Of Drug In Schedule I
50-32-222 - Specific Dangerous Drugs Included In Schedule I
50-32-223 - Criteria For Placement Of Drug In Schedule Ii
50-32-224 - Specific Dangerous Drugs Included In Schedule Ii
50-32-225 - Criteria For Placement Of Drug In Schedule Iii
50-32-226 - Specific Dangerous Drugs Included In Schedule Iii
50-32-227 - Board Authorized To Exempt Certain Compounds, Mixtures, Or Preparations From Schedule Iii
50-32-228 - Criteria For Placement Of Drug In Schedule Iv
50-32-229 - Specific Dangerous Drugs Included In Schedule Iv
50-32-230 - Board Authorized To Exempt Certain Compounds, Mixtures, Or Preparations From Schedule Iv
50-32-231 - Criteria For Placement Of Drug In Schedule V
50-32-232 - Specific Dangerous Drugs Included In Schedule V
50-32-233 - Exempt Anabolic Steroid Products